SELLAS Life Sciences Group Inc (SLS)
1.63
+0.09
(+5.84%)
USD |
NASDAQ |
Apr 23, 16:00
1.64
+0.01
(+0.61%)
After-Hours: 17:52
SELLAS Life Sciences Group Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -1.67K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -242.8% |
| March 31, 2021 | -42.16% |
| December 31, 2020 | -195.6% |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -855.5% |
| March 31, 2014 | -116.7% |
| December 31, 2013 | |
| September 30, 2013 | -793.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.67K%
Minimum
Mar 2022
-42.16%
Maximum
Mar 2021
-538.7%
Average
-219.2%
Median
Profit Margin (Quarterly) Benchmarks
| Geron Corp | -226.0K% |
| Immuneering Corp | -- |
| Protagonist Therapeutics Inc | 45.56% |
| Akebia Therapeutics Inc | 1.09% |
| Moderna Inc | 7.71% |